Another Iranian study on the effects of omega-3 (1,000 mg, including 120 mg and 180 mg of DHA and EPA, respectively, for 6 weeks) on glucose metabolism in 56 women with GDM, did not show the efficacy of supplementation on the reduction of fasting insulin, insulin sensitivity or lipid profile, but confirmed the efficacy in reducing inflammation parameters in the intervention group (hs-PCR −236.3 ± 1,541.9 vs. 898.6 ± 2,292.7 ng/mL, P = 0.03) (146). Here, INS is linked to gestational diabetes.